MedTrace Logo

Effect of the Enriched Environment on the Risk of Relapse

NCT05577741 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 135

Last updated 2026-01-13

No results posted yet for this study

Summary

This clinical study investigates the effects of enriched environment on the risk of relapse in alcoholic patients.

135 patients hospitalized for an alcoholic addiction will be recruited and randomized in two groups: one group will receive standard of care, the other group will receive a treatment with enriched environment.

The enriched environment consists of six sessions of virtual reality (20 minutes) in a multi-sensory pod and six sessions (20 minutes) of bike activity with cognitive tasks while pedalling.

The multi-sensory virtual reality pod allows mindfulness practice and allows patients to be in immersive situations that may trigger cues in order to help them in craving management.

The bike consists in the combination of a pedal set and a touch pad on which cognitive training games are offered. This tool thus makes it possible to simultaneously stimulate motor skills and cognition by means of bicycle-game coupling.

Patients are then followed during 3 months and a half.

Conditions

  • Alcoholic Relapse

Interventions

BEHAVIORAL

Multisensory virtual reality pod (SENSIKS©)

Six sessions of 20 minutes of mindfulness.

BEHAVIORAL

Cognitive bike (Vélo-cognitif®)

Six sessions of 20 minutes of cognitive bike (pedal + cognitive games).

OTHER

Standard treatment

Standard of care treatment

Sponsors & Collaborators

  • Centre Hospitalier Henri Laborit

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-29
Primary Completion
2025-07-09
Completion
2025-07-09

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05577741 on ClinicalTrials.gov